Illumina Q3 2016 Financial Results

Illumina reported Q3 2016 financial results with revenue of $607 million, reflecting 10% year-over-year growth driven by sequencing consumables and microarrays, offset by lower sequencing instrument sales. Operating margin contracted to 34.4% from 36.0% primarily due to increased investments in headcount and growth initiatives including GRAIL and Helix.